Tianjin, China

Juan Gao

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Asymchem Laboratories (Fuxin) Co., Ltd., Asymchem Laboratories (Tianjin) Co., Ltd., Jilin Asymchem Laboratories Co., Ltd.. Active years: 2021-2023.


% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Juan Gao in Proline Hydroxylase

Introduction

Juan Gao is an accomplished inventor based in Tianjin, China. He has made significant contributions to the field of biochemistry, particularly in the development of proline hydroxylase. His work has led to advancements that enhance the catalytic activity of this important enzyme.

Latest Patents

Juan Gao holds two notable patents related to proline hydroxylase. The first patent describes a proline hydroxylase that includes a specific amino acid sequence with mutations that enhance its activity. The second patent also focuses on a proline hydroxylase with a similar sequence and mutations, which provide higher catalytic specificity compared to previous versions. These innovations are crucial for various applications in biotechnology and pharmaceuticals.

Career Highlights

Throughout his career, Juan Gao has worked with prominent companies such as Asymchem Laboratories and Tianjin Asymchem Pharmaceuticals. His experience in these organizations has allowed him to collaborate on cutting-edge research and development projects.

Collaborations

Juan has worked alongside talented individuals, including Hao Hong and Gage James. Their combined expertise has contributed to the success of their projects and innovations.

Conclusion

Juan Gao's contributions to the field of proline hydroxylase exemplify the impact of innovative research in biotechnology. His patents and collaborations highlight the importance of teamwork in advancing scientific knowledge.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…